DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Biopharma (1808)

39 Biopharma Reports

  • breast cancer
Treatment for breast cancer (CaB) in the United States has matured as...
Treatment for breast cancer (CaB) in the United States has matured as oncologists have formalized protocols around specific patient populations, namely HER2+, HR+/HER2-, and HR-/HER2- (also known a......
Last Updated 16 September 2014 Owing to its large population, the treatment of...
Last Updated 16 September 2014 Owing to its large population, the treatment of breast cancer remains an active area of research with a rich and diverse product pipeline. A competitiv......
Oncology indications increasingly use predictive biomarkers to guide prescribing...
Oncology indications increasingly use predictive biomarkers to guide prescribing of costly therapies. However, uptake of targeted therapies in Brazil is highly dependent on incorporation into priva......
Oncology indications increasingly use predictive biomarkers to guide prescribing...
Oncology indications increasingly use predictive biomarkers to guide prescribing of costly therapies. However, uptake of targeted therapies in Mexico and Argentina is highly dependent on their inco......
Breakthrough therapy designation was introduced by the FDA in 2012 to expedite...
Breakthrough therapy designation was introduced by the FDA in 2012 to expedite the drug development process for promising novel therapies for serious or life-threatening conditions. In 2013, of 28......
1 - 20 of 39